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NCHHSTP’s vision:  
A future free of HIV, viral hepatitis, STDs, and tuberculosis.
NCHHSTP’s mission:  
Save lives, protect people, and reduce health disparities  
associated with HIV, viral hepatitis, STDs, and TB.
Every year, millions of Americans are infected with HIV, viral hepatitis, STDs, or TB and tens of thousands die from their infection.  Most of these infections share commonalities, from modes of transmission to demographic, social and economic conditions that increase risk.  CDC’s National Center for HIV, Viral Hepatitis, STD and TB Prevention (NCHHSTP) leads 
prevention and control efforts to reduce incidence, morbidity, mortality, and health disparities  
due to these infections. 
Focus Diseases
STDs: Nearly 20 million STDs occur in the 
U.S. each year; about half occur among teens 
and young adults.  STDs can cause infertility, 
ectopic pregnancy, cancer, and increased  
HIV risk. The healthcare costs from new  
STDs, excluding HIV, that occur each year,  
are approximately $3.7 billion.
HIV: More than 1.2 million persons in U.S.  
are infected with HIV. Estimated lifetime 
treatment costs are $402,000 per person 
living with HIV. 
Viral Hepatitis: Approximately 4.4 
million people are living with chronic viral 
hepatitis infection. Viral Hepatitis is the leading 
causes of liver cancer and liver transplants 
in the U.S. Curing hepatitis C costs $45,000 to 
$94,000 per person.
Tuberculosis: Fewer than 10,000 cases 
of TB occur annually in in the U.S.  11 million 
Americans are infected with the bacteria that 
causes TB. Without treatment, these Americans 
are at risk of developing active TB disease. 
Drug susceptible TB costs, on average, $17,000 
per year to treat, a figure that rises to $134,000 
if the person has multiple drug resistant TB, and 
$430,000 if the case is extensively drug resistant.
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Disease Interactions 
Infection with syphilis or gonorrhea 
increase the risk of acquiring or 
transmitting HIV. 
Infection with HIV makes a person 
more susceptible to TB disease. 
Co-infection with HIV and either 
Hepatitis B or Hepatitis C increases 
the risk for liver-related morbidity 
and mortality. 
Guiding principle: High Impact Prevention
Through high impact prevention, NCHHSTP prioritizes cost-effective and scalable programs, 
policies, and research to achieve the greatest public health impact possible.  It recognizes that 
all interventions are not effective and all effective interventions are not equally scalable or cost-
effective. 








Establish cost and 
cost effectiveness 
per infections averted 
and life-years saved 
Determine feasibility 
of full scale 
implementation 
Develop epidemic 












Target, prioritize, and improve 
programs using surveillance 
data; other program data; 
and modeling, evaluation and 
research results
More timely, accurate, and complete data on 
risk behaviors and infections.




Address critical scientific gaps 
by identifying, developing and 
evaluating interventions, policies 
and technologies 
Tools and knowledge needed to increase the 
effectiveness, efficiency and impact of HIV, viral 






Increase knowledge of HIV, 
viral hepatitis, STDs, and 
TB, and promote adoption of 
behaviors that prevent infection 
and associated morbidity and 
mortality
Adults and adolescents with the knowledge and 
skills to establish healthy behaviors, connect to 
health services, and avoid HIV, viral hepatitis, 
STD, TB, and unintended pregnancy. 
Public health and health care professionals 
with the information and necessary skills to 
conduct effective control programs and provide 




Maximize opportunities afforded 
by the healthcare system for 
preventing infections, morbidity 
and mortality
A healthcare system that addresses the needs 
of patients in a more holistic manner, with 
improved quality and delivery of recommended 
preventive services  for HIV, viral hepatitis, STDs 





Promote better collaboration 
across divisions in design and 
implementation of surveillance, 
research, communication, and 
prevention programs to support 
service integration and utilize 
Center and partner resources 
most effectively
Improved effectiveness and efficiency of 
NCHHSTP funded prevention and control 
programs, with shared capacity that can be 
used across programs.   
Organizational 
Excellence
Support excellence in science 
and program; ensure efficient 
business and scientific 
administration; implement 
effective communication and 
policies; enhance skills of current 
staff; and develop the NCHHSTP 
public health workforce 
Improved quality of NCHHSTP scientific, 
programmatic and policy endeavors, as well 
as managerial and administrative activities. An 
effective NCHHSTP workforce that is able to 
meet today’s public health challenges.
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NCHHSTP Goals and Indicators of Progress
NCHHSTP has established three priority goals, and a small set of measurable indicators of progress.  
Additional critical program indicators are monitored by NCHHSTP divisions and funded programs.  
The current set will be amended and updated to reflect changes to national plans or if additional or 
improved data become available. 
Goal 1: Decrease incidence of infection
Indicator Current Result 2020 Target
1.1 Reduce rate of new  diagnoses
1.1.a  HIV 15.0/100,000 (2013) TBD*
1.1.b  Acute hepatitis B in adults 19    
 and older
1.2 symptomatic cases per 
100,000 population (2013)
0.5/100,000
1.1.c  Acute hepatitis C 0.7 symptomatic cases per 
100,000 population (2013)
0.25 symptomatic cases 
per 100,000 population
1.1.d  TB 3.0 cases per 100,000 (2013) 1.4 cases per 100,000 
population
1.2   Reduce the annual rate of increase 
of primary & secondary syphilis
10% (2012 to 2013) 5%
1.3   Increase the percentage of high 
school students nationwide who 
abstained from sexual intercourse 
or, if currently sexually active, who 
used a condom during last sexual 
intercourse
86.3% (2013) 90.6%
Goal 2: Decrease morbidity and mortality 
Indicator Current Result 2020 Target
2.1  Reduce deaths from viral hepatitis
2.1.a Hepatitis B 1,873 (2013) 1,754
2.1.b Hepatitis C 19,368 (2013) 16,370
2.2   Increase the percentage of HIV-diagnosed 
persons aged 18 years and older whose 
most recent HIV viral load test in the 




Indicator Current Result 2020 Target
2.3   Increase the proportion of gonorrhea-
infected patients treated with a CDC-
recommended antibiotic regimen
80.8% (2012) 90%
2.4   Increase the percentage of people who are 
aware of their infection
2.4.a  HIV 86.0% (2011) TBD*
2.4.b  Hepatitis B 33% (2009) 66%
2.4.c  Hepatitis C 49% (2002-2011) 66%
2.5   Increase the percentage of sexually 
experienced high school students 
nationwide who have been tested for HIV
22.4% (2013) 24.6%
2.6   Increase HIV testing among STD clinic 
patients who are diagnosed with an acute 
STD 
72%  of clinic visits  
in 2012
79%
2.7   Increase the percentage of young sexually 
active females who were screened for 
Chlamydia trachomatis infection
Women 16-20: 45.1%  
Women 21-24: 53.2% 
(2013)
Women 16-20: 49.6% 
Women 21-24: 58.5% 
Goal 3: Decrease health disparities  
Indicator Current Result 2020 Target
3.1   Reduce the rate of new diagnoses among racial/ethnic populations with rates above 
the national average
3.1a   Estimated rate of new 
HIV diagnoses (national: 
15/100,000 in 2013)
Black or African American: 
55.9/100,000




Black or African 
American: TBD* 
Hispanic or Latino:  TBD*
Multiple race: TBD*
3.1b   Reported rate of TB  
(national rate:   
3.1/100,000 in 2013) 
Asian: 19.0/100,000
Native Hawaiian or 
Other Pacific Islander: 
12.8/100,000
Hispanic or Latino: 
5.0/100,000
Black or African American: 
5.4/100,000
American Indian or Alaska 
Native: 6.1/100,000
Asian: 14.9/100,000
Native Hawaiian or 
Other Pacific Islander: 
5.5/100,000
Hispanic or Latino: 
2.1/100,000
Black or African 
American: 2.9/100,000
American Indian 
or Alaska Native: 
2.6/100,000
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Indicator Current Result 2020 Target
3.2   Reduce new HIV infections among 
high-risk populations:








3.3   Reduce the number of TB cases  
in foreign-born persons per  
100,000 per year
15.6 per 100,000 (2013) 11.1 cases per 100,000
3.4   Increase the percentage of HIV-
diagnosed men who have sex 
with men (MSM), blacks/African 
Americans, and Hispanics/Latinos 
aged 18 years and older who have 
achieved viral suppression
MSM: 41.7%
Black or African American:
34.9% 




Black or African 
American: 39.2%
Hispanics or Latinos: 
43.9%
3.5   Reduce the percentage of sexual 
minority male high school students 
in major urban centers who have 
engaged in HIV/STD risk behaviors  
34.1% (2013) 30.7% (2019)
*Targets will be set by the National HIV/AIDS Strategy. 
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